» Articles » PMID: 28258412

Reversible Phosphorylation of the 26S Proteasome

Overview
Journal Protein Cell
Date 2017 Mar 5
PMID 28258412
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The 26S proteasome at the center of the ubiquitin-proteasome system (UPS) is essential for virtually all cellular processes of eukaryotes. A common misconception about the proteasome is that, once made, it remains as a static and uniform complex with spontaneous and constitutive activity for protein degradation. Recent discoveries have provided compelling evidence to support the exact opposite insomuch as the 26S proteasome undergoes dynamic and reversible phosphorylation under a variety of physiopathological conditions. In this review, we summarize the history and current understanding of proteasome phosphorylation, and advocate the idea of targeting proteasome kinases/phosphatases as a new strategy for clinical interventions of several human diseases.

Citing Articles

PI31 is a positive regulator of 20S immunoproteasome assembly.

Wang J, Kjellgren A, DeMartino G bioRxiv. 2025; .

PMID: 39868238 PMC: 11761684. DOI: 10.1101/2025.01.15.633194.


Differential Activity and Expression of Proteasome in Seminiferous Epithelium During Mouse Spermatogenesis.

Zapata-Carmona H, Diaz E, Morales P, Jara M Int J Mol Sci. 2025; 26(2).

PMID: 39859218 PMC: 11764840. DOI: 10.3390/ijms26020494.


DNA damage-induced proteasome phosphorylation controls substrate recognition and facilitates DNA repair.

Zhang X, Zhu T, Li X, Zhao H, Lin S, Huang J Proc Natl Acad Sci U S A. 2024; 121(35):e2321204121.

PMID: 39172782 PMC: 11363268. DOI: 10.1073/pnas.2321204121.


Neurodegenerative Proteinopathies Induced by Environmental Pollutants: Heat Shock Proteins and Proteasome as Promising Therapeutic Tools.

Moyano P, Sola E, Naval M, Guerra-Menendez L, de la Cabeza Fernandez M, Del Pino J Pharmaceutics. 2023; 15(8).

PMID: 37631262 PMC: 10458078. DOI: 10.3390/pharmaceutics15082048.


Establishing 20S Proteasome Genetic, Translational and Post-Translational Status from Precious Biological and Patient Samples with Top-Down MS.

Sanchez Dafun A, Zivkovic D, Leon-Icaza S, Moller S, Froment C, Bonnet D Cells. 2023; 12(6).

PMID: 36980185 PMC: 10047880. DOI: 10.3390/cells12060844.


References
1.
Wang X, Chen C, Baker P, Chen P, Kaiser P, Huang L . Mass spectrometric characterization of the affinity-purified human 26S proteasome complex. Biochemistry. 2007; 46(11):3553-65. DOI: 10.1021/bi061994u. View

2.
Finley D . Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem. 2009; 78:477-513. PMC: 3431160. DOI: 10.1146/annurev.biochem.78.081507.101607. View

3.
Petrocca F, Altschuler G, Tan S, Mendillo M, Yan H, Jerry D . A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells. Cancer Cell. 2013; 24(2):182-96. PMC: 3773329. DOI: 10.1016/j.ccr.2013.07.008. View

4.
He Y, Guo X, Yu Z, Wu L, Gunawan A, Zhang Y . A potent and selective inhibitor for the UBLCP1 proteasome phosphatase. Bioorg Med Chem. 2015; 23(12):2798-809. PMC: 4451428. DOI: 10.1016/j.bmc.2015.03.066. View

5.
Lee B, Lee M, Park S, Oh D, Elsasser S, Chen P . Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature. 2010; 467(7312):179-84. PMC: 2939003. DOI: 10.1038/nature09299. View